NMDA-Receptor Antagonists in Neuropathic Pain: Experimental Methods to Clinical Trials
- 31 January 2000
- journal article
- review article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 19 (1) , 21-25
- https://doi.org/10.1016/s0885-3924(99)00125-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral inputPain, 1996
- NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloridePain, 1996
- Central Dysesthesia Pain after Traumatic Spinal Cord Injury Is Dependent on N-Methyl-D-aspartate Receptor ActivationNeurosurgery, 1995
- Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjectsPain, 1995
- Intravenous Infusion of the NMDA Antagonist, Ketamine, in Chronic Posttraumatic Pain with AllodyniaClinical Neuropharmacology, 1995
- Dextromethorphan for the treatment of neuropathic pain: a double-blind randomised controlled crossover trial with integral n-of-1 designPain, 1994
- Relief of post-herpetic neuralgia with the Symbol receptor antagonist ketamine: A double-blind, cross-over comparison with morphine and placeboPain, 1994
- Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepinesTrends in Pharmacological Sciences, 1993
- Sensitization of cat dorsal horn neurons to innocuous mechanical stimulation after intradermal injection of capsaicinBrain Research, 1989
- Comparison of ketamine and pethidine in experimental and postoperative painPain, 1989